Reuters, November 1, 2011. Dr. Diana Zuckerman, president of the National Research Center for Women & Families, talks about the need for stronger conflict of interest rules for the FDA.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Birth-Control Pills Tied to Dangerous Clots: Which Brands?
CBS News, October 27, 2011. Dr. Diana Zuckerman, president of the National Research Center for Women & Families, questions why the FDA approves birth control pills that are less safe and have no benefit compared to drugs already on the market.
Read More »FDA says Yaz and Other Next-Generation Birth Control Drugs Appear to Increase Blood Clot Risk
The Republic, October 27, 2011. NRC President, Dr. Diana Zuckerman tells the Republic about problems with the popular birth control Yaz. She questions why you would take Yaz, the more expensive option that can potentially kill you.
Read More »J&J Vaginal Mesh Approved by FDA Based on Similar Device Recalled in 1999
Bloomberg, October 20, 2011. President of the National Research Center for Women & Families Dr. Diana Zuckerman told Bloomberg that the 501(K) FDA approval process has become a gateway for high-risk medical devices such as joint implants and vaginal mesh that can claim a tie to older products.
Read More »Left to Their Own Devices
The Economist, September 10, 2011. Scandals, recalls, stingy customers, anxious regulators—any one of these would traumatise a chief executive. America’s industry for medical devices is suffering from all of them. Omar Ishrak, the new boss of Medtronic, the world’s biggest medical-technology company, recently described the problem succinctly to analysts: “There is a lot of work ahead of us.”
Read More »